Health/Wellness

From Anthropology to Business: Alternative Pathways Beyond the Academy A Conversation with Mackenzie Cramblitt and Christopher Daley

Cultural Anthropology presents

From Anthropology to Business: Alternative Pathways Beyond the Academy
A Conversation with Mackenzie Cramblitt and Christopher Daley

Monday, September 20, 2021
1:30pm

Join Zoom Meeting

https://duke.zoom.us/j/92289109832
Meeting ID: 922 8910 9832

Mackenzie Cramblit is a management consultant with a focus on organizational culture and change topics. She received her PhD in Cultural Anthropology from Duke University in 2018

Digital Health and Data Science Innovation: Enabling New Models of Care Globally

Digital health and data science holds promise for significant advances in health care access, quality and affordability. Together with our knowledge partner McKinsey & Company, we will be gathering with global leaders in health innovation to discuss how emerging digital technologies could fundamentally shift models of care and bring powerful new tools to both patients and care givers. REGISTRATION REQUIRED.

CRISPR: Rewriting DNA and the Future of Humanity

Nobel Laureate Jennifer Doudna, PhD is a member of the departments of Molecular and Cell Biology and Chemistry at UC Berkeley, the Howard Hughes Medical Institute, and Lawrence Berkeley National Lab, along with the National Academy of Sciences, and the American Academy of Arts and Sciences. Dr. Doudna won the Nobel Prize in Chemistry in 2020 for her work in developing a method for genome editing along with her collaborator and fellow Nobel Laureate Dr. Emmanuelle Charpentier.

Achieving Value through Innovation in Primary Care: A Global Perspective

The Duke Global Health Innovation Center and Vynamic are cohosting this virtual event which will convene health innovators, providers, funders, and public sector officials from across the globe to evaluate the potential for achieving value through innovation in primary care. We will explore new enabling technologies and how these might be combined with innovative financing and policy models to expand access and improve lives. REGISTRATION REQUIRED.

"Evaluation of the VA Pharmacogenomic Testing for Veterans (PHASER) Clinical Program at Initial Test Sites"

Melody Shi, MD, and Olivia Dong, PhD, are two second year fellows in the Genome Medicine and Research T32 Program at Duke University. Each will share a 30-minute talk covering the research they have accomplished in the last two years despite challenges from the Pandemic.

Melody Shi, MD

"Investigating the Role of CYP24 in Mineral Homeostasis"

Olivia Dong, PhD

"Evaluation of the VA Pharmacogenomic Testing for Veterans (PHASER) Clinical Program at Initial Test Sites"

"Precision Approaches for Health Communication with Vulnerable and Underserved Populations"

Suzanne Bakken, RN, PhD, FAAN, FACMI, is the Alumni Professor of Nursing and Professor of Biomedical Informatics at Columbia University. Following doctoral study in nursing at the University of California, San Francisco, she completed a National Library of Medicine postdoctoral fellowship in Medical Informatics at Stanford University. The goal of Dr. Bakken's program of research is to promote health and reduce health disparities in underserved populations through application of innovative informatics methods.

iMED: So You Want To Start A Company

We are lucky to have Dr. Anthony G. Visco, MD, Professor and Chief of the Urogynecology Division and Chair of the DUH Robotic Committee, speak with us about his process of founding NinoMed. Dr. Visco is the President and CEO of NinoMed, which is a medical device and business analytics company that provides a wide variety of healthcare products including:

The Unjamming Transition (UJT) is Fundamental to Wound Healing, Embryonic Development, and Cancer Invasion

Dr. Jeffrey Fredberg's laboratory investigates physical processes expressed by the eukaryotic cell, such as its deformability, contractility, malleability, and motility. His team turned attention more recently from the single cell in isolation to the cellular collective as it might pertain, for example, to disruption of the bronchial epithelial layer in asthma or tumor invasion in breast cancer.

Pages